Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 22, 2025

December 22, 2025

Tevogen CEO Donates Shares to Support Education for Underprivileged Children

GlobeNewswire

December 22, 2025

NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM

GlobeNewswire

December 22, 2025

AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040

GlobeNewswire

December 22, 2025

Le brevet pour le masitinib dans le traitement de la drépanocyose a été officiellement accordé aux Etats-Unis avec une protection jusqu'en 2040

GlobeNewswire

December 22, 2025

The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS

GlobeNewswire

December 22, 2025

PracticeLink Supports the Next Generation of Clinicians with Fall 2025 First Practice Fund Scholarships

GlobeNewswire

December 22, 2025

Dogwood Therapeutics Announces Positive Interim Phase 2b Clinical Trial Results in Chemotherapy Induced Neuropathic Pain

GlobeNewswire

December 22, 2025

Wholeview Wellness Joins the Lumina Therapy Alliance, Expanding Access to In-Person Addiction-Focused Psychotherapy for Employees and Their Families

GlobeNewswire

December 22, 2025

First Health Canada-Approved At-Home COVID-19 and Influenza A/B Combination Test Now Available in Canada Ahead of Flu Season

GlobeNewswire

December 22, 2025

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

GlobeNewswire

December 22, 2025

MISTR & Kim Petras Celebrate Sexual Health in 2026

GlobeNewswire

December 22, 2025

PeopleOne Health Selected by Orlando Regional REALTOR® Association to Deliver First-of-Its-Kind Healthcare Solution for Realtors

GlobeNewswire

December 22, 2025

Omada Health to Participate in J.P. Morgan Healthcare Conference

GlobeNewswire

December 22, 2025

OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025

GlobeNewswire

December 22, 2025

Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)

GlobeNewswire

December 22, 2025

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

December 22, 2025

Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy

GlobeNewswire

December 22, 2025

CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies

GlobeNewswire

December 22, 2025

Vivos Inc Summarzes Preogress in its Animal Therapy Division

GlobeNewswire

December 22, 2025

SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA

GlobeNewswire